Hong Kong SAR
-
China Water Affairs Group is back in the loan market with a $100m club deal. -
Chinese biotechnology company InnoCare Pharma has won final approval for its Hong Kong IPO. The next step is marketing the deal, after delayed investor meetings in February.
-
Independent television producer China Bright Culture Group has launched bookbuilding for its IPO, aiming to raise up to HK$1.35bn ($172.9m).
-
Hengan International, a Hong Kong-listed Chinese producer of sanitary napkins and baby diapers, sold the first coronavirus-linked Panda bond on Friday. The red-chip issuer will spend 13% of the proceeds for the cause.
-
Workers of the world’s capital markets united this week in efforts to keep the funding flowing as the threat of the Covid-19 coronavirus advances. Roadshows, mandate pitches and even quotidian office life faced emergency changes as embattled financiers braced themselves and their businesses for virus disruption.
-
Chinese brokerage Shenwan Hongyuan Securities is out for a one-year bridge loan, seeking HK$3bn ($385m) for its international loan market debut.
-
“What's in a name?” wrote Shakespeare. “That which we call a rose by any other name would smell as sweet.” A banker tried applying a similar philosophy last week. It wasn’t quite so poetic.
-
Perpetual tenors were in favour this week as four borrowers from Greater China sealed perps in a yield-hungry environment.
-
Artificial intelligence company Megvii Technology’s IPO prospectus expired on Tuesday. But despite delaying the deal, the firm intends to resubmit a listing application, according to a source familiar with the matter.
-
Bank of China took Covid-19-linked bonds offshore on Thursday with a dual currency two year transaction, which was offered through its Macau branch.
-
Standard Chartered-backed China Bohai Bank is planning a listing in Hong Kong, having filed a draft prospectus on Wednesday.
-
JP Morgan has picked Filippo Gori as its new chief executive officer for Asia Pacific, replacing Nicolas Aguzin, who is now running the firm’s international private bank.
